nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
A biological classification of Huntington's disease: the Integrated Staging System
|
Tabrizi, Sarah J |
|
|
21 |
7 |
p. 632-644 |
artikel |
2 |
Access to investigational drugs for patients with amyotrophic lateral sclerosis in the USA
|
Lynch, Holly Fernandez |
|
|
21 |
7 |
p. 593-594 |
artikel |
3 |
A cinematic exploration of technology and the brain
|
Kirby, Tony |
|
|
21 |
7 |
p. 595-596 |
artikel |
4 |
A new option for patients with treatment-resistant migraine
|
Ornello, Raffaele |
|
|
21 |
7 |
p. 578-579 |
artikel |
5 |
Cell-based and stem-cell-based treatments for spinal cord injury: evidence from clinical trials
|
Zipser, Carl M |
|
|
21 |
7 |
p. 659-670 |
artikel |
6 |
Comparison of switching to 6-week dosing of natalizumab versus continuing with 4-week dosing in patients with relapsing-remitting multiple sclerosis (NOVA): a randomised, controlled, open-label, phase 3b trial
|
Foley, John F |
|
|
21 |
7 |
p. 608-619 |
artikel |
7 |
Correction to Lancet Neurol 2021; 20: 615–26
|
|
|
|
21 |
7 |
p. e7 |
artikel |
8 |
Correction to Lancet Neurol 2021; 20: 917–29
|
|
|
|
21 |
7 |
p. e7 |
artikel |
9 |
Correction to Lancet Neurol 2022; 21: 417–27
|
|
|
|
21 |
7 |
p. e7 |
artikel |
10 |
Correction to Lancet Neurol 2022; 21: 620–31
|
|
|
|
21 |
7 |
p. e7 |
artikel |
11 |
Epilepsy syndromes: an essential piece of the puzzle
|
The Lancet Neurology, |
|
|
21 |
7 |
p. 577 |
artikel |
12 |
Huntington's disease: disappointments and new beginnings
|
Saft, Carsten |
|
|
21 |
7 |
p. 582-584 |
artikel |
13 |
Imaging of the carotid artery
|
Evans, Nicholas R |
|
|
21 |
7 |
p. 588 |
artikel |
14 |
Imaging of the carotid artery – Authors' reply
|
Brown, Martin M |
|
|
21 |
7 |
p. 588-589 |
artikel |
15 |
Major advances in neuromuscular disorders in the past two decades
|
Wadman, Renske I |
|
|
21 |
7 |
p. 585-587 |
artikel |
16 |
Medieval treatment of epilepsy in England
|
Mohammed, Hamzah |
|
|
21 |
7 |
p. 592 |
artikel |
17 |
Natalizumab for multiple sclerosis: the dilemma of NOVA
|
Hellwig, Kerstin |
|
|
21 |
7 |
p. 579-581 |
artikel |
18 |
Potential disease-modifying therapies for Huntington's disease: lessons learned and future opportunities
|
Tabrizi, Sarah J |
|
|
21 |
7 |
p. 645-658 |
artikel |
19 |
Reasons to be glad
|
West, Leah |
|
|
21 |
7 |
p. 596 |
artikel |
20 |
Safety and efficacy of eptinezumab for migraine prevention in patients with two-to-four previous preventive treatment failures (DELIVER): a multi-arm, randomised, double-blind, placebo-controlled, phase 3b trial
|
Ashina, Messoud |
|
|
21 |
7 |
p. 597-607 |
artikel |
21 |
Surgery versus conservative treatment for traumatic acute subdural haematoma: a prospective, multicentre, observational, comparative effectiveness study
|
van Essen, Thomas A |
|
|
21 |
7 |
p. 620-631 |
artikel |
22 |
Tanuja Chitnis: on role models, family, and multiple sclerosis
|
Burton, Adrian |
|
|
21 |
7 |
p. 591 |
artikel |
23 |
The Mobile Toolbox for monitoring cognitive function
|
Gershon, Richard C |
|
|
21 |
7 |
p. 589-590 |
artikel |
24 |
Tina Charway-Felli
|
|
|
|
21 |
7 |
p. 592 |
artikel |
25 |
Treatment decision making in acute subdural haematoma
|
Brennan, Paul M |
|
|
21 |
7 |
p. 581-582 |
artikel |